We aimed to determine the relationships between resting left ventricular (LV) wall motion abnormalities (WMAs), aortic plaque, and peripheral artery disease (PAD) in a community cohort. A total of 1726 Framingham Heart Study Offspring Cohort participants (806 males, 65 ± 9 years) underwent cardiovascular magnetic resonance with quantification of aortic plaque volume and assessment of regional left ventricular systolic function. Claudication, lower extremity revascularization, and ankle-brachial index (ABI) were recorded at the most contemporaneous examination visit. WMAs were associated with greater aortic plaque burden, decreased ABI, and claudication in age-and sex-adjusted analyses (all p < 0.001), which were not significant after adjustment for cardiovascular risk factors. In age-and sex-adjusted analyses, both the presence (p < 0.001) and volume of aortic plaque were associated with decreased ABI (p < 0.001). After multivariable adjustment, an ABI ≤ 0.9 or prior revascularization was associated with a threefold odds of aortic plaque (p = 0.0083). Plaque volume significantly increased with decreasing ABI in multivariable-adjusted analyses (p < 0.0001). In this free-living population, associations of WMAs with aortic plaque burden and clinical measures of PAD were attenuated after adjustment for coronary heart disease risk factors. Aortic plaque volume and ABI remained strongly negatively correlated after multivariable adjustment. Our findings suggest that the association between coronary heart disease and non-coronary atherosclerosis is explained by cardiovascular risk factors. Aortic atherosclerosis and PAD remain strongly associated after multivariable adjustment, suggesting shared mechanisms beyond those captured by traditional risk factors.
Introduction
Central and peripheral artery disease (PAD) are manifestations of cardiovascular disease (CVD) that carry significant morbidity and mortality. In prospective, population-based studies, the presence and extent of atherosclerotic plaques in the carotid and femoral arteries are associated with increased CVD death. 1, 2 Decreased ankle-brachial index (ABI) is associated with increased risk of congestive heart failure (CHF), coronary heart disease (CHD), and CVD death, 3, 4 and confers increased morbidity and mortality for each category of the Framingham Risk score (FRS). 5 CVD risk increases with greater extent of atherosclerosis across multiple vascular territories. 6 Myocardial ischemia and infarction resulting from CHD is a major cause of resting left ventricular (LV) wall motion abnormalities (WMAs). Echocardiographic resting WMAs correlate with significant angiographic coronary stenoses. 7 In participants with known CHD and LV dysfunction, the presence and severity of resting WMAs are associated with increased morbidity and mortality. 8, 9 In subjects without overt CVD, WMAs may be a marker of silent CHD. 10 Cardiovascular magnetic resonance (CMR) facilitates both qualitative and quantitative measures of LV systolic function, as well as aortic plaque burden. While the extent of polyvascular atherosclerotic disease has been reported, 6 there are few studies that examine the inter-relatedness of WMAs, aortic atherosclerosis, and PAD in an unselected population, particularly including subjects without prevalent CVD. As atherosclerosis has a prolonged subclinical course and correlates with future adverse CVD events, 3, 4 early intervention may prevent the development of overt CVD or recurrent events, provided that similar mechanisms produce atherosclerosis in different vascular beds. We hypothesized that measures of aortic and peripheral atherosclerosis would be associated both with WMAs and with each other in a free-living population.
Methods

Participants
Study participants included a subset of the 3539 participants attending Examination 7 (1998 Examination 7 ( -2001 of the Framingham Heart Study (FHS) Offspring Cohort, which has been described previously. 11 At evaluation every 3-4 years, beginning with Examination 1 (1971) (1972) (1973) (1974) (1975) , participants underwent routine medical history and physical exam, anthropometry, and assessment of CVD risk factors. For the CMR substudy, a random sampling strategy was used to recruit from strata of sex, decade age, and quintile of the FRS. 12 Participants were excluded if they were not in sinus rhythm, had a contraindication to CMR (e.g. pacemaker), or did not live in a state contiguous with Massachusetts. CMR scanning (2002) (2003) (2004) (2005) (2006) was incomplete in 32 participants (claustrophobia, n = 13; scanner dysfunction, n = 7; metallic devices, n = 10; miscellaneous, n = 2). A total of 1726 participants (aged 65 ± 9 years, 806 men) completed CMR with analyzable images. ABI data were available in 1678 of these participants. The study was approved by the institutional review boards of both the Boston University Medical Center and the Beth Israel Deaconess Medical Center. All participants provided written informed consent.
CMR imaging
Supine CMR imaging was performed using a 1.5 T CMR scanner (Gyroscan NT; Philips Medical Systems, Best, The Netherlands) with a five-element commercial cardiac array coil for radio frequency signal reception. Following localizing scans to determine the position and orientation of the heart within the thorax, end-expiratory breath-hold, ECGgated cine steady-state free precession images were acquired in two-chamber, four-chamber, and contiguous short axis orientations (temporal resolution 39 ms, repetition time = R-R interval, echo time 9 ms, flip angle 30 degrees, field of view 400 mm, matrix size 208 × 256, slice thickness 10 mm, gap = 0).
Aortic plaque imaging included 36 transverse slices from the aortic arch to the aortoiliac bifurcation using a free-breathing, ECG-gated, fat-suppressed, black blood T2-weighted turbo spin-echo sequence 13 with 5-mm slice thickness and an in-plane spatial resolution of 1.03 × 0.64 mm (10-mm and 5-mm slice gaps for thoracic and abdominal aorta, respectively).
Image analysis of LV function and aortic plaque
Cine-CMR image analysis was performed using dedicated software (EasyVision 5.1; Philips Medical Systems) by a single observer (C.S.) blinded to all clinical data. LV wall motion was analyzed according to a 17-segment model. 14 WMAs noted by the observer were confirmed by two additional reviewers blinded to all clinical data (C.T., S.Y). The global and regional wall motion score was computed using a five-point scale (1 = normal, 2 = hypokinetic, 3 = akinetic, 4 = dyskinetic, 5 = aneurysm), with the normal sum of all segments scoring 17. The wall motion score index (WMSI) was calculated as the total wall motion score divided by the number of segments, with a WMSI ≥ 19/17 (WMSI > 1.12, WMA) considered abnormal (≥ 2 contiguous hypokinetic segments, and/or one akinetic or dyskinetic segment). 10 Quantitative measures of LV systolic function and mass (LVM) were obtained by manually tracing epicardial and endocardial LV borders at end-diastole and end-systole, as previously described. 11 LV end-diastolic volume (EDV) and end-systolic volume (ESV) were computed using the summation of discs method. The LV ejection fraction (LVEF) was computed by (EDV -ESV)/EDV. The LVM was determined by summing myocardial volume and multiplying by myocardial density (1.05 g/ml). The LVM was indexed to body surface area (BSA). The LVM index (LVMI), relative wall thickness (RWT), LVM/LVEDV, and LVEF were tabulated.
CMR images were analyzed with commercial software (MASS v 6.1; QT-MEDIS, NL, Leiden, The Netherlands) for descending thoracic and abdominal aortic atherosclerotic plaque by a single expert reviewer (N.O.) blinded to all clinical data. 13 Images analyzed were perpendicular to the aorta with > 50% of the inner circumference of the aortic wall visualized. Atherosclerotic plaque was defined as luminal protrusions of ≥ 1 mm in radial thickness 13 that were visually distinguished from the minimal residual blood signal of each plaque. By visually tracing the plaque border, the cross-sectional area of plaque was measured, and total plaque volume was calculated. Inter-and intrareader replicate measurements were made to determine reproducibility. 13 
Clinical variables and assessment of PAD
Participants underwent routine physical examination, anthropometry, and laboratory assessment of CVD risk factors at Examination 7 (1998 Examination 7 ( -2001 . Resting systolic (SBP) and diastolic blood pressure (DBP) were measured in the right arm seated position. Plasma glucose, and total and high-density lipoprotein cholesterol were measured on morning samples after an 8-hour fast. Hypertension was defined as SBP ≥ 140 mmHg or DBP ≥ 90 mmHg or use of antihypertensive medications. Dyslipidemia was defined as a total cholesterol ≥ 200 mg/dl or the use of lipid-lowering therapy. Diabetes mellitus was defined as fasting glucose ≥ 126 mg/dl or the use of insulin or oral hypoglycemic medications. A history of CHD (defined as recognized or unrecognized myocardial infarction [with diagnostic electrocardiography], angina, or coronary insufficiency) and CHF (identified by clinical signs and symptoms) were determined by physician end-point review. 12 The presence of intermittent claudication at any clinic examination visit was defined by a physician-administered questionnaire, in which participants reported exertional leg discomfort related to degree of walking that was relieved with rest, verified by an endpoint review panel of three investigators. 15 Ankle-brachial SBP measurements, repeated twice, were obtained by trained technicians using a standard protocol at Examination 7 (average 4.4 years from CMR study). 15 ABI was calculated for each leg as the ratio of average SBP in the ankle divided by average SBP in the higher arm. The lower of the two ABIs calculated for each lower extremity was used for analysis. If ABI was missing for one lower extremity, data were used from the other extremity. A reported history of lower extremity revascularization, including percutaneous angioplasty, placement of stent, or vascular bypass surgery, was recorded and validated by medical record review. Three categories of ABI were defined: ABI ≤ 0.9 or history of lower extremity revascularization (significant PAD); 0.91 ≤ ABI ≤ 1.0; and 1.0 < ABI ≤ 1.4. Participants with ABI > 1.4 were excluded (n = 7) as these values may represent medial arterial calcification with associated increased mortality. 16 This exclusion resulted in n = 1671 participants with ABI data for analysis.
Statistical analysis
Participants were categorized by the presence or the absence of a WMA. Plaque volume was natural log-transformed due to a non-normal distribution and reported as median (interquartile range). Descriptive statistics for all covariates are presented as percentages or means ± SD. Differences in characteristics between the groups with and without WMAs were evaluated using two-sample t-tests and analysis of covariance (ANCOVA) for continuous variables, and the chi-squared test and logistic regression for binary variables. Age-and sex-adjusted and multivariable-adjusted ANCOVA and logistic regression models were constructed to assess the association of aortic plaque, natural log-transformed plaque volume, claudication, and ABI (as both continuous and categorical variables, using ABI > 1.0 to ≤ 1.4 as the referent group) with the presence or absence of a WMA. Odds ratios and 95% confidence intervals were calculated for the association of categorical variables with WMAs.
Covariates in the multivariable model were determined at Examination 7: age, sex, BMI, tobacco pack-years, SBP, total cholesterol/high-density lipoprotein (HDL) ratio, and histories of hypertension treatment, dyslipidemia treatment, and diabetes mellitus. Similar models were generated to assess the relationship of aortic plaque to ABI severity. An age-and sex-adjusted Pearson correlation coefficient was used to determine the linear association between the presence and quantity of aortic plaque with ABI. All analyses were performed with SAS 8.0 (SAS Institute, Cary, NC, USA). A two-sided p-value < 0.05 was considered statistically significant. The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Results
The demographics and characteristics of the study sample are shown in Table 1 . WMAs were present in 106 (6%) of the total population. Compared to participants without a WMA, those with WMAs had a greater prevalence of all cardiovascular risk factors, particularly male sex, diabetes, and hypertension, and a greater prevalence of CHD or CHF (all p < 0.001). However, 53% of participants with WMAs had no history of CHD or CHF. Participants with WMAs also had greater LVMI and LVEDV, and lower LVEF (all p < 0.0001).
The prevalence of aortic plaque and raw measures of clinical PAD are presented in Table 1 . Aortic plaque was present in 48% of the cohort. The majority of participants with aortic plaque (93%) had normal LV wall motion. Plaque volume was greater in participants with WMAs compared to those with normal wall motion (p < 0.001). This difference persisted after age-and sex-adjustment (p = 0.001) but was attenuated after multivariable adjustment (p = 0.22).
Participants with WMAs had a greater prevalence of both claudication and decreased ABI. Claudication was associated with a nearly fourfold odds of having a WMA in ageand sex-adjusted analyses (OR 3.78, 95% CI 1.68-8.52, p = 0.001); this association was attenuated after multivariable adjustment (OR 1.69, 95% CI 0.66-4.37, p = 0.276). Mean ABI was not significantly lower in participants with a WMA in multivariable adjusted analyses (mean ± SD: 1.11 ± 0.15 vs 1.14 ± 0.10, p = 0.12). ABI ≤ 0.9 or revascularization were present in 42 (2.5%) participants, ABI 0.91-1.0 was present in 76 (4.5%) participants, and ABI > 1.0-1.4 was present in 1553 (92.9%) participants. There was a significant increase in the proportion of participants with WMAs across decreasing levels of ABI (5.5% among ABI > 1.0 to 1.4, 10.5% among ABI 0.91-1.0, and 19.0% among ABI ≤ 0.9 or revascularization, p < 0.001 for linear trend). In age-and sexadjusted analyses, ABI ≤ 0.9 or revascularization was associated with a nearly threefold risk of WMA (OR 2.94, 95% CI 1.28-6.76, p = 0.01) and ABI 0.91-1.0 was associated with an elevated risk for WMAs (OR 2.58, 95% CI 1.13-5.84, p = 0.02) compared to ABI > 1.0 and ≤ 1.4. However, the association between ABI level and WMA was not significant after multivariable adjustment (OR for WMA 1.9, 95% CI 0.78-4.40, p = 0.843, for ABI ≤ 0.9 or revascularization; OR for WMA 0.90, 95% CI 0.32-2.52, p = 0.163, for ABI 0.91-1.0) (Figure 1) .
Odds of a WMA associated with peripheral artery disease (PAD). Boxes represent odds ratio for a WMA; lines represent 95% CI. Claudication, ABI ≤ 0.9 or revascularization, and ABI 0.91-1.0 were associated with increased odds of a WMA in age-and sex-adjusted analyses. These associations were attenuated after multivariable adjustment.
Aortic plaque and ABI were inversely associated. In participants with aortic plaque, ABI was significantly lower compared to those without plaque (ABI = 1.12 ± 0.11 vs 1.15 ± 0.09, p < 0.0001). The prevalence of aortic plaque increased with decreasing ABI category (Figure 2 ). ABI ≤ 0.9 or a history of revascularization was associated with fivefold increase in the odds of aortic plaque in age-and sex-adjusted analyses (OR 4.99, 95% CI 2.184-11.414, p = 0.0014) and a threefold increase in the odds after multivariable adjustment (OR 3.23, 95% CI 1.35-7.73, p = 0.0083). Likewise, median aortic plaque burden also increased with decreasing ABI group, from 0 cm 3 (IQR 0.0-0.39 cm 3 ) among ABI > 1.0 to 1.4, to 0.34 cm 3 (IQR 0.0-1.49 cm 3 ) among ABI 0.91-1.0, to 2.2 cm 3 (IQR 0.23-4.10 cm 3 ) among ABI ≤ 0.9 or with a history of revascularization. This relationship was significant in age-and sex-adjusted analyses (Spearman r = -0.28, p = 0.001), and persisted after multivariable adjustment (p < 0.0001).
Discussion
To our knowledge, this is the first population-based study to evaluate the relationship of LV WMAs, a likely surrogate for CHD, with both aortic and peripheral atherosclerosis. Notably, a significant proportion of participants with WMAs were free of prevalent CHD or CHF. While LV WMAs may result from non-ischemic etiologies, underlying CHD is a common etiology in middle-aged populations in developed countries. 17, 18 The associations between extent of aortic plaque and clinical PAD with LV WMAs seen in age-and sex-adjusted analyses were not significant after multivariable adjustment. However, aortic plaque and ABI remained strongly inversely correlated after adjustment for CHD risk factors. While those with ABI data represented a smaller group, exclusion of these participants did not change the results of the prevalence and mean values of risk factors with the exception of obesity, whose lower prevalence was similar among participants with and without WMAs.
In our community-based population, CMR evidence of aortic plaque was common. Though many participants without WMAs had aortic plaque, this group had a lower overall plaque volume. The high prevalence of aortic plaque in both groups with and without WMAs is consistent with the high prevalence of CVD risk factors, notably hypertension, history of tobacco use, and dyslipidemia throughout the population. The association of increased plaque volume in participants with WMAs was attenuated in multivariable analysis, suggesting that these mechanisms of atherosclerosis in the aorta and coronary arteries have in common traditional CVD risk factors including obesity, smoking, diabetes, hypertension, and dyslipidemia. However, our results are consistent with transesophageal echocardiographic data showing an association of aortic plaque thickness with CHD 19 and an increased incidence of CHD and CVD morbidity in those with aortic calcification. [20] [21] [22] [23] Significant clinical PAD was uncommon in our cohort (2.4% with ABI ≤ 0.9 or revascularization and only 2.3% with claudication), despite the prevalence of CVD risk factors. This is similar to the 2-4% prevalence of ABI ≤ 0.9 reported in an earlier, larger subset of the FHS Offspring Cohort, 15 in the Atherosclerosis Risk in Communities (ARIC) Study, 24 in the Multi-Ethnic Study of Atherosclerosis (MESA), 25 and in a large Italian population. 26 The 8-9% prevalence of significant PAD among those with a WMA was greater than those with normal LV wall motion. The fact that ABI and WMAs were associated in age-and sexadjusted analyses but not upon multivariable adjustment in our study suggests that both ABI and WMAs may be influenced by traditional CVD risk factors. A similar relationship was seen between claudication and WMAs in multivariable analyses.
While attenuated in multivariable analyses, the association between PAD and WMAs is in agreement with findings from the Cardiovascular Health Study, which reported an association between ABI < 0.9 and echocardiographic segmental WMAs and in age-and sex-adjusted analyses. 27 Our results are also consistent with that between decreased ABI and both prevalence and incident development of CHD in the ARIC studies. 24, 28 While an ABI ≤ 0.9 is used as the cut-off for significant PAD, 5 an ABI 0.91-1.0 may reflect an intermediate risk, as this group still had a nearly threefold odds of WMA in age-and sex-adjusted analyses. These results are consistent with reports of both an increased prevalence of CHD 15, 24 and both cohort and meta-analysis studies, demonstrating a greater risk for cardiovascular events and mortality with progressive decreases in ABI. 5, 29 Other studies have found a relationship between coronary artery calcification (CAC), another surrogate for CHD, and PAD. In a subset of 1932 participants without cardiovascular risk factors in MESA, a low ABI (< 1.0) was associated with the presence of CAC. 30 In addition, in a cohort of 3479 participants with CHD, those with concomitant PAD had a greater volume of coronary atheroma and extent of CAC. 31 Our study may show a lack of association in adjusted analyses due to the limited number of participants with PAD or due to the indirectness of WMAs as a marker of coronary artery disease as compared to CAC. In contrast, both the prevalence and burden of aortic plaque demonstrated a strong inverse relationship with groups of ABI independent of traditional CVD risk factors. The stronger association of measures of non-coronary atherosclerosis with each other than with WMAs could reflect that WMAs are the result of a clinical event which may not correlate with absolute degree of atherosclerosis. This is consistent with past angiographic evidence that often angiographic severity may result from lesser grade, rather than highly stenotic lesions. 32 Alternatively, factors promoting atherosclerosis in coronary as compared with non-coronary beds may have different mechanisms. Consistent with this possibility, members of the Reduction of Atherothrombosis for Continued Health (REACH) cohort with PAD had a markedly greater prevalence of polyvascular disease than did those with CAD (60% vs 25%, respectively). 6 CMR is advantageous as it is not limited by acoustic windows, generates standard imaging planes, and defines wall motion at the apex with higher precision than echocardiography. 33 We were able to assess LV wall motion in 99% of all participants and complete aortic plaque analysis in 96% of participants. This technique has been well-validated in the assessment of LV function 34 and imaging atherosclerotic plaque. 13 Limitations of this study include a relatively small number of participants with clinical PAD and WMAs, which may have limited the power to detect associations between PAD and WMAs. In addition, Examination 7 data and CMR data were not obtained concurrently. While there was an average of 4.4 years between Examination 7 and the CMR test, this time interval would be more likely to bias true associations towards the null. Furthermore, assessment of regional WMAs remains largely observer-dependent, though CMR allows superior endocardial border definition and thus excellent interobserver agreement. 35 While the majority of WMAs (94%) reflected regional rather than global LV dysfunction, 6% of WMAs were global. This minority of WMAs could represent non-ischemic cardiomyopathy with no significant coronary artery disease. Finally, the FHS Offspring Cohort is a predominantly middle-aged and older Caucasian population. Thus, our results may not be generalizable to other races or ethnicities or age groups.
In conclusion, in this community-based population, incidentally detected WMAs which likely reflect CHD were associated with measures of aortic and peripheral atherosclerosis in age-and sex-adjusted, but not multivariable-adjusted models. The prevalence and burden of aortic plaque were strongly and independently associated with peripheral artery disease in both age-and sex-and multivariable-adjusted analyses. WMAs and peripheral atherosclerosis share common CVD risk factors. However, aortic atherosclerosis and PAD remain strongly associated after multivariable adjustment, suggesting shared mechanisms beyond those captured by traditional risk factors. While screening for WMAs is not advocated in a CHD at-risk population, unsuspected WMAs may be identified during imaging. Further prospective studies are necessary to determine the clinical utility of detection of WMAs relative to other markers of CHD.
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